静脉注射的特兰胺酸对整个关节整形手术 (PRADO研究) 周围手术期间血红蛋白下降的剂量效应关系:随机,双盲,安慰剂控制,剂量反应研究的研究方案
Paul Jacques Zufferey1,2,3, Emeric Barrat4, Béatrice Deygas2
1Department of Anaesthesia and Intensive Care, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France paul.zufferey@chu-st-etienne.fr.
BMJ open
|December 3, 2025
概括
这项研究调查了全关节整形术 (THA) 的最佳静脉注射松酸 (TXA) 剂量,以最大限度地减少血液损失. 这些发现将指导精确的TXA管理,以改善THA手术期间患者的血液储存.
科学领域:
- 麻醉学 麻醉学
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 众所周知,手术前的松酸 (TXA) 可以减少关节整形术 (THA) 中的血液损失.
- 为了最大限度地减少THA的血液节约作用,最佳的静脉注射TXA剂量仍未确定.
- 之前的研究已经探索了有限的TXA剂量范围,需要进一步调查.
研究的目的:
- 在接受THA的患者中,确定静脉TXA的剂量反应关系.
- 为了确定TXA的最佳剂量,以减少外科手术期间的血红蛋白下降.
- 为了提高THA手术中TXA的节血效果.
主要方法:
- 一个单心,双盲,安慰剂控制,剂量确定研究,涉及150名随机选择的成年患者接受THA.
- 患者接受了安慰剂或四种静脉注射TXA剂量之一 (300 mg,500 mg,1000 mg或3000 mg).
- 主要结局是术后第3天的相对外周血红蛋白下降,使用非线性混合效应模型进行分析.
主要成果:
- 这项研究旨在确定THA中静脉TXA的剂量反应曲线.
- 分析的重点是确定最大限度地降低血红蛋白下降的TXA剂量.
- 二级结局包括TXA暴露和D-二次体水平,以评估纤维溶解活性.
结论:
- 确定TXA的精确剂量反应对于优化其在THA中的使用至关重要.
- 这项研究旨在为TXA剂量提供基于证据的建议,以改善外科手术期间的血液管理.
- 这些发现将有助于在全关节整形术中进行更安全,更有效的外科手术.
相关概念视频
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
185
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
185
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K


